{'fraction_non_alphanumeric': 0.03912363067292645, 'fraction_numerical': 0.003129890453834116, 'mean_word_length': 4.925925925925926, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Response to: ‘Overlap of systemic lupus erythematosus and myositis is rare in anti-Ku antibody-positive patients’ by Ogawa-Momohara et al

We thank Ogawa-Momohara et al for their comment1 on our work in which we identified that anti-Ku patients with elevated serum creatine kinase (elevated CK) are at risk of interstitial lung disease (ILD), whereas anti-Ku patients with anti-double-strand DNA (dsDNA) antibodies frequently have systemic lupus erythematosus (SLE) and are at risk of glomerulonephritis.2

The data reported by Ogawa-Momohara et al importantly complete our results since none of our anti-Ku patients had an Asian origin. …